Provenienza dei contatti di primo grado di Ralf Morgenstern
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Gesynta Pharma AB
Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden.
11
| Holding Company | Pharmaceuticals: Major | 11 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Ralf Morgenstern tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Life Science Group, Inc. | Medical Specialties | Corporate Officer/Principal | |
Athera Biotechnologies AB
Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman | |
VITROLIFE AB | Medical Specialties | General Counsel | |
University of Oxford | College/University | Undergraduate Degree | |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Karolinska Institutet | College/University | Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
University of Cambridge | College/University | Doctorate Degree | |
OREXO AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Executive Officer | |
Copenhagen Business School | College/University | Graduate Degree | |
Stockholm School of Economics | College/University | Graduate Degree | |
Biolipox AB
Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Chief Executive Officer | |
CAMURUS AB | Pharmaceuticals: Major | General Counsel | |
University of Lund | College/University | Graduate Degree | |
International Institute for Management Development | College/University | Undergraduate Degree | |
BioCrine AB | Director/Board Member | ||
BIOSERVO TECHNOLOGIES AB | Medical Specialties | Director/Board Member | |
Liberum Capital Ltd.
Liberum Capital Ltd. Investment Banks/BrokersFinance Panmure Liberum Capital Ltd. (Panmure Liberum) is a brokerage firm headquartered in London, UK. The firm was founded by Shane Le Prevost in 2007 as Liberum Capital Ltd. In 2024, Panmure Liberum Ltd. (now known as LIB 123 Ltd.) acquired the firm from TN Holdings (BVI) Ltd. Headquartered in London, Liberum provides trading and execution services for institutional clients. They bring liquidity into the niches that matter and are market-makers in various large, mid and small-cap stocks. | Investment Banks/Brokers | Analyst-Equity | |
MOBERG PHARMA AB | Pharmaceuticals: Major | Director/Board Member | |
AnaMar AB
AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
KDev Exploratory AB
KDev Exploratory AB Miscellaneous Commercial ServicesCommercial Services KDev Exploratory AB provides drug discovery solutions. It performs discovery research in various therapeutic areas, such as screening in oncology, neuroscience, lead finding, characterization in inflammation and angiogenesis/age-related macular degeneration. The company was founded by David Jern in 2000 and is headquartered in Solna, Sweden. | Miscellaneous Commercial Services | Chief Operating Officer | |
The European Society of Cardiology | Director/Board Member | ||
Axcentua Pharmaceuticals AB
Axcentua Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Axcentua Pharmaceuticals AB develops anti-cancer drugs for pancreatic cancer patients. It generates investigational new drugs for diseases with unmet medical need in Sweden. The firm offers AXP107-11, multi-targeted chemosensitizer and a small-molecule anti-cancer compound for the treatment of various solid tumors, such as non-small cell lung cancers. The company was founded in 2007 by Anders Berkenstam, Stefan Rehnmark and Michael-Robin Witt and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Chairman | |
The Swedish Bar Association | Corporate Officer/Principal | ||
NovaSAID AB
NovaSAID AB Pharmaceuticals: MajorHealth Technology NovaSAID AB develops treatments for inflammation and pain in conditions such as rheumatoid arthritis. It discovers selective microsomal prostaglandin E synthase-1 (mPGES-1), and has also demonstrated its effect in animal models for pain and inflammation. The firm's approach is to prevent the pathological formation of prostaglandin E2 (PGE2) selectively, through the development of inhibitors of mPGES-1, the enzyme that is responsible for the formation of PGE2 during inflammation. Its mPGES-1 inhibition offers an approach for inhibiting pathological PGE2 production without adversely affecting other important prostanoids. The company was founded by Per-Johan Göte Jakobsson, Ralf Morgenstern, Bertil Samuelsson and Bengt Ingemar Samuelsson on October 26, 2004 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Founder Corporate Officer/Principal | |
Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt
Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt Miscellaneous Commercial ServicesCommercial Services Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt is a non-profit organization based in Stockholm, Sweden. and has subsidiaries in Sweden. The organization's main objective is to raise funds for selected Swedish heart and lung research to help people live longer and healthier lives. The Swedish company works together with individuals and companies to collect and distribute funds for heart and lung research. The organization's vision is to create a world free from heart and lung disease. Kärlkramp, which is a temporary reduction of blood flow in the heart's coronary vessels and the main symptom is a squeezing chest pain, is one of the diseases they focus on. | Miscellaneous Commercial Services | Director/Board Member | |
KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Director/Board Member Chief Operating Officer | |
Brf-Bellman | Chairman | ||
Cormorant Pharmaceuticals AB
Cormorant Pharmaceuticals AB BiotechnologyHealth Technology Cormorant Pharmaceuticals AB provides biopharmaceutical products.The company was founded by Maarten de Chateau and Urban Paulsson in 2010 and is headquartered in Solna, Sweden. | Biotechnology | Director/Board Member Founder | |
Betagenon Sweden AB
Betagenon Sweden AB Pharmaceuticals: MajorHealth Technology Betagenon AB engages in development of AMP-activated protein kinase (AMPK) activator compounds chronic energy balance disorders diseases. The company was founded by Helena Edlund, Thomas Edlund and Olof Karlsson and is headquartered in Umea, Sweden. | Pharmaceuticals: Major | Chairman | |
NANEXA AB | Medical Specialties | Director/Board Member | |
CERENO SCIENTIFIC AB | Pharmaceuticals: Major | Director/Board Member | |
LIPIGON PHARMACEUTICALS AB | Pharmaceuticals: Major | Chairman | |
IRLAB THERAPEUTICS AB | Pharmaceuticals: Major | Chief Executive Officer | |
Nordia Law
Nordia Law Miscellaneous Commercial ServicesCommercial Services Nordia Law provides legal services. The private company is based in Stockholm, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Nylof Holding AB
Nylof Holding AB Investment Banks/BrokersFinance Nylof Holding AB provides security brokerage services. The private company is based in Stockholm, Sweden. | Investment Banks/Brokers | Director/Board Member | |
Cinclus Pharma Holding AB
Cinclus Pharma Holding AB BiotechnologyHealth Technology Cinclus Pharma Holding AB is a Swedish clinical-stage pharma company and it operates as a holding company through its subsidiaries. It develops small molecules for treatment of stomach acid related diseases with a focus on the diseases GastroEsophageal Reflux Disease (GERD) and Helicobacter Pylori Infection. The company was founded by Hansson Stig Lennart, Unge Peter, Kjell Andersson and Paulsson Urban in 2014 and is headquartered in Stockholm, Sweden. | Biotechnology | Founder | |
Cavis Technologies AB | Chairman | ||
Molecules of Man AB
Molecules of Man AB BiotechnologyHealth Technology Molecules of Man AB develops human monoclonal antibodies for treatment. The private company is based in Stockholm, Sweden. | Biotechnology | Chairman | |
Collective Minds Radiology AB
Collective Minds Radiology AB Packaged SoftwareTechnology Services Collective Minds Radiology AB provides a cloud-based healthcare service that enables collaboration, consultation, and access to new digital tools. The company is based in Danderyd, Sweden. The Swedish company was founded in 2017 by Pär Kragsterman, Anders Nordell, and Lennart Blomqvist. Anders Nordell has been the CEO since 2017. | Packaged Software | Director/Board Member | |
Buzzard Pharmaceuticals AB
Buzzard Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Buzzard Pharmaceuticals AB develops oncology drugs. The company is based in Stockholm, Sweden. The Swedish company was founded by Urban Paulsson. The CEO is Maarten de Château. | Pharmaceuticals: Major | Founder | |
Evident Life Försäkring AB | Chairman | ||
Cordivest AB | Chairman | ||
Urban Paulsson AB | Chairman | ||
Olsson Solutions AB | Director/Board Member | ||
MetaCurUm Biotech AB | Chairman | ||
Betagenon Bio AB | Chairman |
Statistiche
Distribuzione geografica
Svezia | 40 |
Stati Uniti | 6 |
Regno Unito | 4 |
Danimarca | 2 |
Svizzera | 2 |
Settori
Health Technology | 25 |
Consumer Services | 8 |
Commercial Services | 5 |
Finance | 4 |
Technology Services | 2 |
Posizioni
Director/Board Member | 73 |
Corporate Officer/Principal | 30 |
Independent Dir/Board Member | 16 |
Chairman | 15 |
Founder | 10 |
Contatti più connessi
- Borsa valori
- Insiders
- Ralf Morgenstern
- Connessioni Società